Navigation Links
Lipids in the brain an important factor for Alzheimer's disease?
Date:12/10/2007

formed they cannot disappear or be transformed into another structure. Ivo Martins, Joost Schymkowitz and Frederic Rousseau (VIB, Vrije Universiteit Brussel), and Inna Kupperstein and Bart De Strooper (VIB, K.U.Leuven) have shown that certain lipids normally occurring in the brain can destabilize the fibrils, and therefore also the plaque that is so typical of Alzheimer's disease. The liberated protofibrils are toxic for brain cells, causing them to die off at least in vitro. The researchers were able to show that this also happens in vivo by injecting laboratory animals (mice) with the protofibrils. This caused memory loss in the mice. The researchers explain that these symptoms are comparable with those of early stage dementia in humans.

Producing protofibrils for new applications in medicine

The discovery opens up a new avenue of research into possible medicines against Alzheimer's disease. It indicates that substances that neutralize the toxicity or the formation of protofibrils might be able to be used as medicines against Alzheimer's disease. With the discovery of a method for producing toxic protofibrils, the researchers at the VIB have provided a good model for finding medicines that could counteract the formation of protofibrils. Their research also indicates that the concentration of lipids in the brain greatly influences the biological equilibrium between non-toxic plaques and toxic oligomeres. These results open up new avenues of research into the effects of fat metabolism for diseases such as Alzheimer's.


'/>"/>

Contact: Sooike Stoops
info@vib.be
329-244-6611
VIB (the Flanders Institute for Biotechnology)
Source:Eurekalert

Page: 1 2

Related biology news :

1. Chemists get grip on slippery lipids
2. Invasion of the brain tumors
3. HIV is a double hit to the brain
4. AIDS interferes with stem cells in the brain
5. 60 second test could help early diagnosis of common brain diseases
6. U of MN researchers discover noninvasive diagnostic tool for brain diseases
7. U of Minnesota researchers discover noninvasive diagnostic tool for brain diseases
8. Influence of sex and handedness on brain is similar in capuchin monkeys and humans
9. Inside the brain of a crayfish
10. Specific brain protein required for nerve cell connections to form and function
11. Brains timing linked with timescales of the natural visual world

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2009)... , This release is available in German . ,...instrument wouldn,t be a bad thing. It could help ...ble to measure. However, it must do so constructiv...ical measurement with more than just imagination, ...ysics have formulated a theory of spatial percepti...
(Date:11/23/2009)... , This release is available in German . ,...ace a long journey every year. Researchers at Prin... Institute for Ornithology in Radolfzell, Germany ...ant family of bats, the so-called "Vespertilionida...overed that the migration over short as well as lo...
(Date:11/22/2009)... , CINCINNATI -- Children exposed prenatally to t...articularly high risk for ADHD, according to resea... Center. , The study estimates that up to 35 per... 8 and 15 could be reduced by eliminating both of ...e into up to 800,000 children , "Tobacco and le...
Breaking Biology News(10 mins):Visual assistance for cosmic blind spots 2Visual assistance for cosmic blind spots 3Visual assistance for cosmic blind spots 4We're off then: The evolution of bat migration 2Exposure to lead, tobacco smoke raises risk of ADHD 2UC Riverside research on barley genome gets boost from 241 million USDA grant 9853 1UC Riverside research on barley genome gets boost from 241 million USDA grant 9853 2UC Riverside research on barley genome gets boost from 241 million USDA grant 9853 3UC Riverside research on barley genome gets boost from 241 million USDA grant 9853 4Hanson Technologies Inc Awarded Patent for its Advanced Food Pathogen Detection System 13956 1Hanson Technologies Inc Awarded Patent for its Advanced Food Pathogen Detection System 13956 2MRSA May Succumb to Honey 56675 1MRSA May Succumb to Honey 56675 2
...sociation of Biology Teachers (NABT) will recogniz...niversity of Minnesota, with the 2008 Evolution Ed... be held 15-18 October 2008 in Memphis, Tennessee.... by the American Institute of Biological Sciences ...y (BSCS). The award is presented in recognition o...
...ted as to the exact cell type that produces connec... the wound healing process. This knowledge gap is ...Fibrogenesis & Tissue Repair , a new open access j...rmally induced during tissue repair while elevated...rosis. In the paper Andrew Leask and his colleague...
... may hitch a ride on the wind, but a new study in ...l Press publication, confirms that they are anythi...rent Biology offered the first evidence that Silv...s, sailing on favorable winds to reach their south...ow, the research team that brought us that finding...
Other Biology News:Biologists, educators recognize excellence in evolution education 2Biologists, educators recognize excellence in evolution education 3Closing the gap: Journal launch brings together wound-healing knowledge 2Migratory moths may hitch their rides, but they're anything but drifters 2
(Date:11/23/2009)...InimexPharmaceuticals,Inc.announcedtodaythatithasa...,, Abramsbringsmorethan25yearsofdrugdiscoveryan...henuclearmedicineimagingagent,Cardiolite,andworked...r,BiomedicalResearchWorldwide.In1996,Abramsledthee...dCEOfrom1996to2006.AnorMEDdiscoveredanddevelopedMo...
(Date:11/23/2009)...rstCall/--CornerstoneTherapeuticsInc.(Nasdaq: CRTX...ng,developingandcommercializingsignificantproducts...nnouncedthatCraigA.Collard,PresidentandChiefExecut...21stAnnualPiperJaffrayHealthCareConferenceat3:30PM...linNewYorkCity. ,, Aliveaudioandarchivedwebcast...
(Date:11/20/2009)...ire/ -- Veridiam (www.veridiam.com) won the presti...ry at the 2009 Workplace Excellence Awards. The aw...man Resources Management and recognize innovative ...eridiam was one of nine winners, selected from mor...t the recent awards ceremony. San Diego-based Veri...
(Date:11/20/2009)... 20 Karolinska Development AB toda...) has entered into a,co-investment agreement with ...d by Karolinska Development and used to invest in ...cal and medical technology companies. EIF,has agre...d. The agreement,represents EIF,s largest single i...
Breaking Biology Technology:Inimex Announces Appointment of New CEO 2Cornerstone Therapeutics to Present at the 21st Annual Piper Jaffray Health Care Conference 2Veridiam Wins Workplace Excellence Crystal Award in Mid-Size Company Category 2Karolinska Development and EIF Start Landmark Co-Investment Fund for Life Science Innovation 2Karolinska Development and EIF Start Landmark Co-Investment Fund for Life Science Innovation 3
...J., Jan. 31 Schering-Plough,Corporation (NYSE: S...dministration (FDA) has accepted the Peg-IFN (pegi...Application (sBLA) for review and has,granted Prio...atients with,Stage III melanoma. Schering-Plough s... of 2007., The Priority Review designation is int...
...l School Researchers Used Thermo Scientific Dharma...for Reproduction of the Virus that ...1 Thermo Fisher,Scientific Inc., the world leader...interference (RNAi) technology has enabled a groun...n, which identified human proteins,required for gr...
...Manufacture ARIUS, Product Candidate Trop-2 Signal...PRINCETON, N.J., Jan. 31 Laureate Pharma, Inc., a...rotein production company, today,announced that it...reement,with ARIUS Research, Inc., a biotechnology... next wave of antibody therapeutics to treat cance...
Other Biology Technology:FDA Grants Priority Review for Schering-Plough's Peginterferon Alfa-2b for the Adjuvant Treatment of Patients With Stage III Melanoma 2FDA Grants Priority Review for Schering-Plough's Peginterferon Alfa-2b for the Adjuvant Treatment of Patients With Stage III Melanoma 3FDA Grants Priority Review for Schering-Plough's Peginterferon Alfa-2b for the Adjuvant Treatment of Patients With Stage III Melanoma 4FDA Grants Priority Review for Schering-Plough's Peginterferon Alfa-2b for the Adjuvant Treatment of Patients With Stage III Melanoma 5FDA Grants Priority Review for Schering-Plough's Peginterferon Alfa-2b for the Adjuvant Treatment of Patients With Stage III Melanoma 6Research Using Thermo Fisher Scientific RNA-Interference Technology Unveils Potential New Targets for HIV Drugs 2Research Using Thermo Fisher Scientific RNA-Interference Technology Unveils Potential New Targets for HIV Drugs 3Research Using Thermo Fisher Scientific RNA-Interference Technology Unveils Potential New Targets for HIV Drugs 4Research Using Thermo Fisher Scientific RNA-Interference Technology Unveils Potential New Targets for HIV Drugs 5Laureate Announces Manufacturing Agreement with ARIUS for Trop-2 Targeting Antibody 2Laureate Announces Manufacturing Agreement with ARIUS for Trop-2 Targeting Antibody 3
Rabbit Anti-HMGB1 Polyclonal Antibody, Unconjugated from Abcam
ERalpha (Ser104 / Ser106) from Santa Cruz Biotechnology, Inc.
Agarose, pulse field from GE Healthcare, formerly Amersham Biosciences
Agarose, pulse field from GE Healthcare, formerly Amersham Biosciences
Biology Products: